PUBLISHER: Grand View Research | PRODUCT CODE: 1362892
PUBLISHER: Grand View Research | PRODUCT CODE: 1362892
The global orthopedic biomaterials market size is expected to reach USD 35.90 billion by 2030, registering a CAGR of 7.8% from 2023 to 2030. Increasing incidence of degenerative joint disease and musculoskeletal disorders is the key factor driving the market. In addition, increasing geriatric population susceptible to orthopedic conditions arising due to low bone density and advancing bone related disorders is expected to boost the product demand over the forecast period.
Ceramics & bioactive glass was the dominant material type segment in 2022 on account of growing demand for these materials due to their high compression strength. In addition, ceramics & bioactive glass biomaterials are preferred over their counterparts as they have a high affinity to integrate with the surface material of the bone. However, polymer biomaterial segment is expected to witness the fastest CAGR from 2023 to 2030 owing to high usage of these materials for the reconstruction and fixation procedures of the spine, hip, and knee.
Orthopedic implants led the application segment in 2022 and are expected to remain dominant over the forecast period. Increasing number of trauma cases is one of the major factors driving the growth of this segment. Orthobiologics segment is anticipated to witness the fastest CAGR of 7.7% from 2023 to 2030. Increasing adoption of biomaterials in various orthobiologics for the treatment of spinal and other reconstructive surgeries is anticipated to drive the growth of this segment.
Led by U.S. North America led the market in 2022 owing to high demand for joint replacement/reconstruction, bone repair, and, other orthopedic procedures due to the presence of target population. Moreover, rise in the demand for advanced treatment options coupled with increasing awareness about bio-resorbable products is expected to drive the product demand in future.